SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000849146-22-000027
Filing Date
2022-05-03
Accepted
2022-05-03 16:05:50
Documents
48
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lfvn-20220331.htm   iXBRL 10-Q 1205389
2 EX-31.1 lfvn_033122xex311.htm EX-31.1 9732
3 EX-31.2 lfvn_033122xex312.htm EX-31.2 9712
4 EX-32.1 lfvn_033122xex321.htm EX-32.1 5035
5 EX-32.2 lfvn_033122xex322.htm EX-32.2 5015
  Complete submission text file 0000849146-22-000027.txt   4802242

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lfvn-20220331.xsd EX-101.SCH 26952
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lfvn-20220331_cal.xml EX-101.CAL 55974
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lfvn-20220331_def.xml EX-101.DEF 104150
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lfvn-20220331_lab.xml EX-101.LAB 419256
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lfvn-20220331_pre.xml EX-101.PRE 242274
42 EXTRACTED XBRL INSTANCE DOCUMENT lfvn-20220331_htm.xml XML 712536
Mailing Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043
Business Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043 801-432-9000
Lifevantage Corp (Filer) CIK: 0000849146 (see all company filings)

IRS No.: 841097796 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35647 | Film No.: 22886806
SIC: 2834 Pharmaceutical Preparations